SLEW OF TRIALS LAUNCH TO TEST CORONAVIRUS TREATMENTS IN CHINA
Top Cited Papers
- 1 February 2020
- journal article
- news
- Published by Springer Science and Business Media LLC in Nature
- Vol. 578 (7795), 347-348
- https://doi.org/10.1038/d41586-020-00444-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- First Case of 2019 Novel Coronavirus in the United StatesNew England Journal of Medicine, 2020
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)Nature Reviews Drug Discovery, 2020
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Research, 2020
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVNature Communications, 2020
- A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spikeScience Advances, 2019
- Convalescent plasma: new evidence for an old therapeutic tool?2015